chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 67.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Hot flush, Hyperhidrosis, SARS-CoV-2 test, Skin odour abnormal, Taste disorder
Clinical narrative: hot flashes; Sweating; bad taste; Body odor; This spontaneous case was reported by a consumer and describes the occurrence of HOT FLUSH (hot flashes), HYPERHIDROSIS (Sweating), TASTE DISORDER (bad taste) and SKIN ODOUR ABNORMAL (Body odor) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076cz1a) for COVID-19 vaccination.    Co-suspect product included non-company product NIRMATRELVIR, RITONAVIR (PAXLOVID) for COVID-19 treatment.    Concurrent medical conditions included Blood pressure high, High cholesterol, Obesity and Penicillin allergy.   On 24-Sep-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-May-2022, the patient started NIRMATRELVIR, RITONAVIR (PAXLOVID) (unknown route) at an unspecified dose. On 13-May-2022, the patient experienced HOT FLUSH (hot flashes), HYPERHIDROSIS (Sweating), TASTE DISORDER (bad taste) and SKIN ODOUR ABNORMAL (Body odor). At the time of the report, HOT FLUSH (hot flashes), HYPERHIDROSIS (Sweating), TASTE DISORDER (bad taste) and SKIN ODOUR ABNORMAL (Body odor) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Positive.         No concomitant medications were reported.  The patient did not take any other medications or products within 2 weeks of starting COVID-19 treatment.  Device date was reported as 16-May-2022.
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: got really sick; This spontaneous case was reported by an other health care professional and describes the occurrence of ILLNESS (got really sick) in a 93-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (got really sick). At the time of the report, ILLNESS (got really sick) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications details were not reported by the reporter.  Treatment details were not reported by the reporter.   This case was linked to MOD-2022-568298 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Hepatic enzyme increased, Immunisation reaction, Influenza like illness
Clinical narrative: Vaccination adverse reaction; Flu like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of IMMUNISATION REACTION (Vaccination adverse reaction) and INFLUENZA LIKE ILLNESS (Flu like symptoms) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Ulcerative colitis.    No Medical History information was reported.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (Vaccination adverse reaction) and INFLUENZA LIKE ILLNESS (Flu like symptoms). At the time of the report, IMMUNISATION REACTION (Vaccination adverse reaction) and INFLUENZA LIKE ILLNESS (Flu like symptoms) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Hepatic enzyme increased: increased (High) Increased.         No concomitant medications were provided by the reporter.  Patient had received the co-suspect product HUMIRA with daily dose of CF.  No treatment medications were provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Nausea
Clinical narrative: dizziness; Nauseous; This spontaneous case was reported by a patient and describes the occurrence of DIZZINESS (dizziness) and NAUSEA (Nauseous) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A22A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pfizer (1st dose), Pfizer (1st booster) and Pfizer (2nd dose). Past adverse reactions to the above products included No adverse event with Pfizer, Pfizer and Pfizer.    On 19-May-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-May-2022, the patient experienced DIZZINESS (dizziness) and NAUSEA (Nauseous). At the time of the report, DIZZINESS (dizziness) and NAUSEA (Nauseous) had not resolved.            No concomitant medication was reported. The allergies (medications, food and other products) included as unknown. It was unknown that the patient had COVID positive test or diagnosis. Medical History relating to mentioned AE and both Acute and Chronic illnesses at the time of vaccination was unknown. Recent change in status such as improvement or worsening was unknown. Other vaccines given within 1 month prior to Moderna COVID-19 vaccine was unknown. The AE did not cause the patient to seek medical care (office visit, Urgent care, ER, hospitalized). It was unknown the patient experienced a similar event n past. The symptoms was worsened.  No treatment medication was reported.
Sex: U
Vaccine: COVID19
Symptoms: Accidental underdose
Clinical narrative: given half-dose for the 2nd dose (primary series); This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (given half-dose for the 2nd dose (primary series)) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ACCIDENTAL UNDERDOSE (given half-dose for the 2nd dose (primary series)). At the time of the report, ACCIDENTAL UNDERDOSE (given half-dose for the 2nd dose (primary series)) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication details was reported. No treatment medication details was reported.  It was reported that they looked at the CDC's recommendation but the patient cannot come back today until Monday or Tuesday. They want to know if there is any additional information to the CDC's recommendation or if this has been reported.
Sex: U
Vaccine: COVID19, UNK
Symptoms: Chest discomfort, Cough
Clinical narrative: Rebound nonproductive cough; chest tightness; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Rebound nonproductive cough) and CHEST DISCOMFORT (chest tightness) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product NIRMATRELVIR, RITONAVIR (PAXLOVID) for COVID-19 treatment.    The patient's past medical history included Reactive airways disease. Previously administered products included for Product used for unknown indication: Aspirin, SULFA [SULFANILAMIDE], NSAIDS and OXYCODONE. Past adverse reactions to the above products included Allergy with Aspirin, NSAIDS, OXYCODONE and SULFA [SULFANILAMIDE]. Concurrent medical conditions included Hypertension, Anxiety, Obesity, Obstructive sleep apnea syndrome, Irritable bowel syndrome, Lung disease and GERD.   On 27-Aug-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-May-2022, the patient started NIRMATRELVIR, RITONAVIR (PAXLOVID) (Oral) at an unspecified dose. On 18-May-2022, the patient experienced COUGH (Rebound nonproductive cough) and CHEST DISCOMFORT (chest tightness). At the time of the report, COUGH (Rebound nonproductive cough) and CHEST DISCOMFORT (chest tightness) was resolving.            No concomitant medication was provided by the reporter  Patient had history of reactive airway disease. Patient was not taking any other medications/products within 2 weeks of starting COVID-19 treatment. Device date was reported as 19-May-2022.  No treatment medication was provided by the reporter.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tinnitus
Clinical narrative: After receiving the the first booster patient developed tinnitus; This spontaneous case was reported by a patient and describes the occurrence of TINNITUS (After receiving the the first booster patient developed tinnitus) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Patient never had COVID positive test or diagnosis. No history related to mentioned both Acute and Chronic similar past illnesses at the time of vaccination. No other vaccines given within 1 month prior to Moderna COVID-19 vaccine.  Concurrent medical conditions included Seasonal allergy (Just seasonal allergies).   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TINNITUS (After receiving the the first booster patient developed tinnitus). At the time of the report, TINNITUS (After receiving the the first booster patient developed tinnitus) outcome was unknown.            Patient stated that she does take medication but not reported which medication exactly. She did not provide a calendar date instead she stated she received the 2nd dose 28 after the 1st dose.   After receiving the first booster patient developed tinnitus, but it got worse not horrible but worsened after the 2nd booster. Treatment medication was not provided by the reporter.   This case was linked to MOD-2022-572021 (Patient Link).   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Psoriasis
Clinical narrative: Psoriasis flare-up; This spontaneous case was reported by a consumer and describes the occurrence of PSORIASIS (Psoriasis flare-up) in an adult female patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PSORIASIS (Psoriasis flare-up). At the time of the report, PSORIASIS (Psoriasis flare-up) outcome was unknown. Not Provided          No concomitant medications were provided.  On an unknown date, the patient administered the solution of injection of Skyrizi (risankizumab) with dose of 150 milligram by subcutaneous route. The patient had reported the liquid was cloudy of Skyrizi.  No treatment medications were provided.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Product storage error; Expired moderna vaccines administered to 5 patients; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired moderna vaccines administered to 5 patients) and PRODUCT STORAGE ERROR (Product storage error) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 032F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Jan-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 31-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired moderna vaccines administered to 5 patients). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Product storage error). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired moderna vaccines administered to 5 patients) and PRODUCT STORAGE ERROR (Product storage error) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   On 28-Dec-2021, vials were moved from freezer to refrigerated conditions   No concomitant medications were reported  No treatment medications were reported  The vial did not undergo any temperature excursions   Most recent FOLLOW-UP information incorporated above includes: On 20-May-2022: Followup document contain secondary reporter Info and refrigeration date were updated
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: The vial was moved from the freezer to refrigerated conditions on 28-DEC-2021; Expired moderna vaccines administered to 5 patients; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired moderna vaccines administered to 5 patients) and PRODUCT STORAGE ERROR (The vial was moved from the freezer to refrigerated conditions on 28-DEC-2021) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 032F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Feb-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 07-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired moderna vaccines administered to 5 patients). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was moved from the freezer to refrigerated conditions on 28-DEC-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired moderna vaccines administered to 5 patients) and PRODUCT STORAGE ERROR (The vial was moved from the freezer to refrigerated conditions on 28-DEC-2021) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  The vial did not undergo any temperature excursions.  The vial was moved from the freezer to refrigerated conditions on 28-DEC-2021.  No treatment medications were reported   Most recent FOLLOW-UP information incorporated above includes: On 20-May-2022: Follow up received contains Non significant information, Reporter information was added.
Age: 17.0
Sex: U
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 3 minors were given Moderna Covid-19 vaccine booster doses (0.25mL); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (3 minors were given Moderna Covid-19 vaccine booster doses (0.25mL)) in a 17-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041J1A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pfizer Covid-19 vaccine (dose 2) and Pfizer Covid-19 vaccine (dose 1). Past adverse reactions to the above products included No adverse event with Pfizer Covid-19 vaccine and Pfizer Covid-19 vaccine.    On 23-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 23-Dec-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (3 minors were given Moderna Covid-19 vaccine booster doses (0.25mL)). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (3 minors were given Moderna Covid-19 vaccine booster doses (0.25mL)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided by the reporter. The patient had received First booster dose of Moderna vaccine on 23-Dec-2021. It was unknown if patient received other vaccines within one month prior to any dose of Moderna COVID-19 Vaccine. No treatment medication was provided by the reporter.   This case was linked to MOD-2022-572158, MOD-2022-572185 (Patient Link).
Age: 16.0
Sex: U
Vaccine: COVID19
Symptoms: Interchange of vaccine products, Product administered to patient of inappropriate age
Clinical narrative: 3 incidents in clinic where 3 minors were given Moderna Covid-19 vaccine booster doses (0.25mL).; They each received doses 1 & 2 of Pfizer Covid-19 vaccine prior to receipt of Moderna booster; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (3 incidents in clinic where 3 minors were given Moderna Covid-19 vaccine booster doses (0.25mL).) and INTERCHANGE OF VACCINE PRODUCTS (They each received doses 1 & 2 of Pfizer Covid-19 vaccine prior to receipt of Moderna booster) in a 16-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045L21A) for COVID-19 vaccination.     Previously administered products included for Drug use for unknown indication: PFIZER BIONTECH COVID-19 VACCINE (2nd dose) and PFIZER BIONTECH COVID-19 VACCINE (1st dose). Past adverse reactions to the above products included No adverse event with PFIZER BIONTECH COVID-19 VACCINE and PFIZER BIONTECH COVID-19 VACCINE.    On 28-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (3 incidents in clinic where 3 minors were given Moderna Covid-19 vaccine booster doses (0.25mL).) and INTERCHANGE OF VACCINE PRODUCTS (They each received doses 1 & 2 of Pfizer Covid-19 vaccine prior to receipt of Moderna booster). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (3 incidents in clinic where 3 minors were given Moderna Covid-19 vaccine booster doses (0.25mL).) and INTERCHANGE OF VACCINE PRODUCTS (They each received doses 1 & 2 of Pfizer Covid-19 vaccine prior to receipt of Moderna booster) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication reported. No treatment medication reported.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: Covid medication to boost immunity and it made her kind of out of it for a bit; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Covid medication to boost immunity and it made her kind of out of it for a bit) in a 57-year-old female patient who received mRNA-1273 (Spikevax) for COVID-19 immunisation.    Co-suspect product included non-company product TREPROSTINIL SODIUM injection for Primary pulmonary hypertension.    Concurrent medical conditions included Pulmonary arterial hypertension.   On 16-Apr-2021, the patient started TREPROSTINIL SODIUM (Subcutaneous) 0.047 microgram/kilogram, continuing. On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Covid medication to boost immunity and it made her kind of out of it for a bit). At the time of the report, FEELING ABNORMAL (Covid medication to boost immunity and it made her kind of out of it for a bit) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       No concomitant medications were reported.  Patient also had trouble charging the Remodulin Remunity new pumps, with software changes and new cords. Patient tried using the old cords and everything worked correctly. Patient  stated that it might have been their outlet. The patient refused replacement cords. Treprostinil sodium (SQ Remodulin) was reported as continuing (prefilled with 2.4ml per cassette, pump rate 24 mcl/hour). NDA number was reported as 21-272.  No treatment medications were reported.
Age: 10.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Loss of consciousness, Presyncope, Syncope
Clinical narrative: Syncope or near syncopal episode, patient was at school, felt lightheaded and passed out during a chorus practice.   He immediately woke up, felt weak and was sent home.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Confusional state, Dizziness, Fall, Flushing, Hyperhidrosis
Clinical narrative: Systemic: Confusion-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Flushed / Sweating-Severe, Systemic: Nausea-Medium, Systemic: Visual Changes/Disturbances-Medium, Additional Details: Patient blacked out and fell to the floor, he was unresponsive for a couple of seconds then regained consciousness.  He felt better after 5-10 minutes.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Loss of consciousness, Nausea, Unresponsive to stimuli, Visual impairment
Clinical narrative: Systemic: Confusion-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Flushed / Sweating-Severe, Systemic: Nausea-Medium, Systemic: Visual Changes/Disturbances-Medium, Additional Details: Patient blacked out and fell to the floor, he was unresponsive for a couple of seconds then regained consciousness.  He felt better after 5-10 minutes.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Chills, Dehydration, Dysgeusia, Injection site erythema
Clinical narrative: Site: Redness at Injection Site-Severe, Systemic: Body Aches Generalized-Severe, Systemic: Chills-Severe, Systemic: metalic taste, dehydration, burning sensation-Severe, Additional Details: Severely dehydrated to point where doctor prescribed IV drip for patient.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Site: Redness at Injection Site-Severe, Systemic: Body Aches Generalized-Severe, Systemic: Chills-Severe, Systemic: metalic taste, dehydration, burning sensation-Severe, Additional Details: Severely dehydrated to point where doctor prescribed IV drip for patient.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Palpitations
Clinical narrative: i am having frequent heart palpitations. This happened after the first booster. They lasted about 2 months and then disappeared
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Arrhythmia, Condition aggravated
Clinical narrative: Arrhythmia was noticed by cardiologist approximately 2 weeks after first booster, at the time no association was made between the two.  Second Booster was on 5/18/2022 noticeable signs of Arrhythmia noticed after 2-3 days.  Normal heatbeat 60-65, went to 130-133, with blood pressure 115/(90-100).
Age: 72.0
Sex: M
Vaccine: VARZOS
Symptoms: Immediate post-injection reaction, Syncope, Unresponsive to stimuli, Vomiting
Clinical narrative: Systemic: Fainting / Unresponsive-Mild, Systemic: Vomiting-Mild, Additional Details: patient recieved both shingrix and pfizer booster in the right arm. immediately after administration, patient became unresponsive (silent, eyes still open, unresponsive to our calls), lasting for about 1 minute. Patient then requested a trash bin and proceeded to vomit. Patient's condition returned to normal and he refused our offer to call for additional medical assistance.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Laboratory test normal, Seizure
Clinical narrative: Patient had seizure at home
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Immediate post-injection reaction, Tinnitus
Clinical narrative: Patient noted loud Tinnitus. Immediately after getting covid vaccine within 10-15 minutes unrelenting since. Saw specialist post vaccine and not good treatment available
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: COVID POSITIVE PT FULLY VACCINATED ADMITTED WITH COVID
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Pfizer on 7/29/21, 8/19/21. Positive on 5/23/22
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: hospitalization of a fully vaccinated person for covid
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, COVID-19, Cough, Fatigue, Malaise
Clinical narrative: Breakthrough case of Covid - 05/19/2022 Sx started on 05/19/2022, I was coughing, runny nose and very very tired all that day.  The next day I took a test, I was not nearly as tired but coughed a lot, it felt like a sinus infection.  I did a telehealth visit with my APRN and was asked to come in to the office, were they did another test and they gave me some medicine. I was prescribed Paxlovid and an antibiotic amoxicillin. Today is the first day I've felt pretty good, I am not coughing as much, I have the same type of sx only less. I have a metallic taste from the medicine, but I can taste my food, my bowels are not really normal. I have not had any trouble breathing, my SPO2 at it's lowest was 95 so my O2 is good. I tend to run a low temp in low 97's and my temp only went up slightly.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test positive, Sinusitis, Vaccine breakthrough infection
Clinical narrative: Breakthrough case of Covid - 05/19/2022 Sx started on 05/19/2022, I was coughing, runny nose and very very tired all that day.  The next day I took a test, I was not nearly as tired but coughed a lot, it felt like a sinus infection.  I did a telehealth visit with my APRN and was asked to come in to the office, were they did another test and they gave me some medicine. I was prescribed Paxlovid and an antibiotic amoxicillin. Today is the first day I've felt pretty good, I am not coughing as much, I have the same type of sx only less. I have a metallic taste from the medicine, but I can taste my food, my bowels are not really normal. I have not had any trouble breathing, my SPO2 at it's lowest was 95 so my O2 is good. I tend to run a low temp in low 97's and my temp only went up slightly.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Bell's palsy, Muscle spasms
Clinical narrative: Bell's Palsy, muscle spasms
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, Endotracheal intubation, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough covid infection. Acute respiratory failure requiring intubation on 5/23/2022
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Chills, Myalgia, Nausea, Pyrexia
Clinical narrative: subjective fever, chills, nausea, vomiting, myalgias, generalized abdominal soreness. May just be side effects to her booster shot.  She also states she had urticaria 1-2 days after her second dose of moderna .
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria, Vomiting
Clinical narrative: subjective fever, chills, nausea, vomiting, myalgias, generalized abdominal soreness. May just be side effects to her booster shot.  She also states she had urticaria 1-2 days after her second dose of moderna .
Age: 12.0
Sex: M
Vaccine: MNQ
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Vaccine was double administered. Patient received Menactra vaccine on 5/6/22 at his pediatrician's office. Parent had signed consent for vaccine to be administered at school, this RN administered the Menactra vaccine on 5/18/22 at school. System was reviewed prior to vaccine administration on 5/18/22 and there was no documentation of dose given on 5/6/22. No adverse effects reported after dose administered on 5/18/22.
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient administered expired dose of Pfizer COVID-19 vaccine.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMRV
Symptoms: Erythema, Gait disturbance, Induration, Oedema, Pain
Clinical narrative: left thigh was diffusely erythematous and edematous down to just above the knee. Warm to touch, slightly indurated.  Mother reported the patient had been itching the area a lot.  Outside of the area of primary erythema, there was several surrounding wheal-like erythematous areas to the left thigh concerning for urticaria.  Mother initially reported he seemed to have pain when walking on the leg, however on exam the area seemed nontender (although difficult to communicate as the patient is nonverbal, he is autistic). Patient was also jumping up and down in exam room and did not show signs of discomfort.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMRV
Symptoms: Pruritus, Skin warm
Clinical narrative: left thigh was diffusely erythematous and edematous down to just above the knee. Warm to touch, slightly indurated.  Mother reported the patient had been itching the area a lot.  Outside of the area of primary erythema, there was several surrounding wheal-like erythematous areas to the left thigh concerning for urticaria.  Mother initially reported he seemed to have pain when walking on the leg, however on exam the area seemed nontender (although difficult to communicate as the patient is nonverbal, he is autistic). Patient was also jumping up and down in exam room and did not show signs of discomfort.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Dyspnoea, Fatigue, Headache
Clinical narrative: I woke up Saturday morning 5/21 and thought I was getting a sinus infection. But I went ahead and did a home Covid test and the line was very faint so I wasn't sure on the results. I did another and the results were still unclear so I went to the pharmacy to be tested and those results came back positive on Monday, 5/23. I was pretty sick that Saturday night and was up coughing most of the night. I called my health care provider after receiving my positive results. The nurse I ended up speaking with informed me that they would refer my information to their Covid team for review. A few hours later they called and informed me of a PAXLOVID prescription that was being called in for me. I began taking that yesterday on 5/23. I am still feeling tired and winded, I also have a headache and coughing. I also have been experiencing a terrible taste in my mouth.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, SARS-CoV-2 test positive, Sleep disorder, Taste disorder
Clinical narrative: I woke up Saturday morning 5/21 and thought I was getting a sinus infection. But I went ahead and did a home Covid test and the line was very faint so I wasn't sure on the results. I did another and the results were still unclear so I went to the pharmacy to be tested and those results came back positive on Monday, 5/23. I was pretty sick that Saturday night and was up coughing most of the night. I called my health care provider after receiving my positive results. The nurse I ended up speaking with informed me that they would refer my information to their Covid team for review. A few hours later they called and informed me of a PAXLOVID prescription that was being called in for me. I began taking that yesterday on 5/23. I am still feeling tired and winded, I also have a headache and coughing. I also have been experiencing a terrible taste in my mouth.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Deep vein thrombosis, Intensive care, Joint dislocation, Pain in extremity, Pulmonary embolism
Clinical narrative: On about April 5/6 2021 I had dislocated my rib in which I was placed in ICU at my work to recover. During that time I began to fell pain in my right leg calf area.  When I was released I still had pain and it gradually got worse in which then I went back and it was discovered that my right calf was 1 inch larger then then my left & a ultrasound was conducted in which a blood clot was discovered. Approximately 2 weeks after discovering the blood clot I was sent to have testing and visuals done and was notified I had DVT and PE. I received treatment receiving medication for approximately 6-7 months. A few months following behind the conclusion of my treatment  I found out I  yet again had received another blood clot in my right leg. I had no signs of discomfort with this blood clot but was sent to the ER for verification due to signs of PE and DVT again at a OBGYN appointment.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Thrombosis, Ultrasound Doppler abnormal
Clinical narrative: On about April 5/6 2021 I had dislocated my rib in which I was placed in ICU at my work to recover. During that time I began to fell pain in my right leg calf area.  When I was released I still had pain and it gradually got worse in which then I went back and it was discovered that my right calf was 1 inch larger then then my left & a ultrasound was conducted in which a blood clot was discovered. Approximately 2 weeks after discovering the blood clot I was sent to have testing and visuals done and was notified I had DVT and PE. I received treatment receiving medication for approximately 6-7 months. A few months following behind the conclusion of my treatment  I found out I  yet again had received another blood clot in my right leg. I had no signs of discomfort with this blood clot but was sent to the ER for verification due to signs of PE and DVT again at a OBGYN appointment.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: hospitalization with covid; fully vaccinated
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Bronchitis, Oropharyngeal pain, SARS-CoV-2 test negative, Sinusitis
Clinical narrative: 1 week after vaccination- Sore throat, sinus infection, bronchitis  APPEARS unrelated.  I may have picked it up from other co-workers who had similar symptoms.
Age: 17.0
Sex: M
Vaccine: COVID19, FLUX, MEN
Symptoms: Muscular weakness, Nervous system disorder, Systemic lupus erythematosus
Clinical narrative: Developed muscle weakness and motor nerve inflammation in a GBS-like disease in the setting of lupus and recent vaccinations: Influenza 10/4/2021, COVID #1 10/8/21 and has received second one (exact date unknown), MCV4 10/4/21.  Reporting to VAERS for evaluation of relationship to vaccines.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Blood test, Malaise, Ultrasound liver
Clinical narrative: See previous notes.
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Angioedema
Clinical narrative: Angioedema about 12 hours after vaccine, hospitalized for one nigh unknown - done at a Pharmacy,
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dysphagia, Dyspnoea, Hypoaesthesia oral, Mouth swelling, Oral pain
Clinical narrative: Angioedema about 12 hours after vaccine, hospitalized for one nigh unknown - done at a Pharmacy,
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Speech disorder
Clinical narrative: Angioedema about 12 hours after vaccine, hospitalized for one nigh unknown - done at a Pharmacy,
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Breast inflammation, Hypertension, Lymphadenopathy
Clinical narrative: A day later participant notice Breast inflammation, Lymph nodes were swollen. High blood pressure issues for three days. Went to see doctor and was prescribed Prednisone.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Disturbance in attention, Endometrial cancer stage II, Feeling abnormal, Hysteroscopy abnormal, Postmenopausal haemorrhage
Clinical narrative: From July 2021 on I have had brain fog, unable to concentrate. In March 31, 2022 I had post menopausal bleeding. I underwent a hysteroscopy and a dilation & curettage and found stage 2 grade 2 endometrial/uterine cancer. I am having a full hysterectomy June 16, 2022.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Uterine cancer, Uterine dilation and curettage
Clinical narrative: From July 2021 on I have had brain fog, unable to concentrate. In March 31, 2022 I had post menopausal bleeding. I underwent a hysteroscopy and a dilation & curettage and found stage 2 grade 2 endometrial/uterine cancer. I am having a full hysterectomy June 16, 2022.
Age: 13.0
Sex: M
Vaccine: COVID19, COVID19, HPV9
Symptoms: Incorrect dose administered
Clinical narrative: Pt was given a pediatric dose of Pfizer covid vaccine at the age of 13y.  Per physicians instructions pt was then given Pfizer 12+ vaccine to equal a total adult dose of the vaccine.  No adverse effects of vaccination noted or reported
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Respiratory tract congestion, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough Covid infection.  No adverse event related to vaccine itself.  Tested positive (home test) 5/6/22, Called Dr. office and started Paxlovid 5/6/22 evening. Completed 5 day dosing as prescribed. Retested 5/11 (home test) positive. 5/13/22 (home test) negative.   Symptoms: low grade fever for 2-3 days, cough, congestion (relatively mild).  Mild residual cough through present date.  Self isolation for 6 days and then masking until tested negative.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute kidney injury, Decreased appetite, Hyperkalaemia, Laboratory test abnormal, Large intestine perforation
Clinical narrative: 64 y.o. female with significant comorbidities of essential hypertension, T2DM, moderate COPD (PFTs 2020), restrictive lung disease of obesity with OHS, chronic right-sided heart failure, VTE on rivaroxaban, and more recent history of spontaneous colonic perforation in March 2022. Presented to ED with nausea, poor appetite, generalized malaise and muscular weakness and was found to have severe hyperkalemia and AKI.  Tested positive upon admission
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Malaise, Muscular weakness, Nausea
Clinical narrative: 64 y.o. female with significant comorbidities of essential hypertension, T2DM, moderate COPD (PFTs 2020), restrictive lung disease of obesity with OHS, chronic right-sided heart failure, VTE on rivaroxaban, and more recent history of spontaneous colonic perforation in March 2022. Presented to ED with nausea, poor appetite, generalized malaise and muscular weakness and was found to have severe hyperkalemia and AKI.  Tested positive upon admission
Age: 64.0
Sex: M
Vaccine: UNK
Symptoms: Abdominal pain upper, Body temperature increased
Clinical narrative: Stomach pain and spike body temp
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vomiting
Clinical narrative: VOMITTING  AND NAUSEA
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Gait disturbance, Infection, Joint swelling, Knee arthroplasty, Prosthesis user
Clinical narrative: 05/19/2022, I had a knee replacement 16 years ago. My knee began to swell, it felt hot. My big toe on my right foot was swollen, a little red and hot. On that same foot, the right ankle was swollen and hot. I had to get my old walker out to walk around because I was so unsteady. 05/20/2022, I went to my orthopedist. He took x-rays, did a physical exam and looked at my right foot as well. He said the prosthesis was not loose. He did not feel it was infected. He thought, perhaps, I had gout. He said I had a little bit of an infection. He prescribed an anti-inflammatory and told me to return in 2 weeks. It is now much better.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Skin reaction, Skin warm, Swelling, Walking aid user, X-ray normal
Clinical narrative: 05/19/2022, I had a knee replacement 16 years ago. My knee began to swell, it felt hot. My big toe on my right foot was swollen, a little red and hot. On that same foot, the right ankle was swollen and hot. I had to get my old walker out to walk around because I was so unsteady. 05/20/2022, I went to my orthopedist. He took x-rays, did a physical exam and looked at my right foot as well. He said the prosthesis was not loose. He did not feel it was infected. He thought, perhaps, I had gout. He said I had a little bit of an infection. He prescribed an anti-inflammatory and told me to return in 2 weeks. It is now much better.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Fatigue, Oropharyngeal pain, Pain
Clinical narrative: Approximately a few weeks after my booster shot (Dose 3) I contracted COVID-19 and had the following symptoms: fever, chills, congestion, body aches, fatigue, sore throat. I took Tylenol and some cold medicine for treatment, it did help improve my symptoms. Overall it lasted at least around 10 days for me to recover from my symptoms.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: Approximately a few weeks after my booster shot (Dose 3) I contracted COVID-19 and had the following symptoms: fever, chills, congestion, body aches, fatigue, sore throat. I took Tylenol and some cold medicine for treatment, it did help improve my symptoms. Overall it lasted at least around 10 days for me to recover from my symptoms.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Encephalitis autoimmune, Magnetic resonance imaging head abnormal, White matter lesion
Clinical narrative: Autoimmune encephalitis
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Skin reaction, Urticaria
Clinical narrative: three days following vaccination I began having itchy, red hives all over my body, bilaterally including knees, ears, fingers, thighs.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Dysphonia, Fatigue, Headache, Hyperhidrosis
Clinical narrative: Breakthrough case of COVID 05/08/2022. Fever stayed with me, sweats, headache, no cough, a little hoarseness and scratchy throat and exhaustion, went through the course of PAXLOVID then started with a stuffy nose, nothing fierce, could be allergies form the pollen. It lasted about 4 days, before the 5th day I was feeling better. I am really glad I got that booster.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Nasal congestion, Pyrexia, SARS-CoV-2 test positive, Throat irritation, Vaccine breakthrough infection
Clinical narrative: Breakthrough case of COVID 05/08/2022. Fever stayed with me, sweats, headache, no cough, a little hoarseness and scratchy throat and exhaustion, went through the course of PAXLOVID then started with a stuffy nose, nothing fierce, could be allergies form the pollen. It lasted about 4 days, before the 5th day I was feeling better. I am really glad I got that booster.
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Abdominal discomfort, Blood bilirubin increased, Chills, Decreased appetite, Fatigue
Clinical narrative: Jaundice, weight loss, fatigue, malaise, appetite loss, nausea, chills, digestive discomfort
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Hepatic enzyme, Jaundice, Malaise, Nausea, Ultrasound scan
Clinical narrative: Jaundice, weight loss, fatigue, malaise, appetite loss, nausea, chills, digestive discomfort
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Weight decreased
Clinical narrative: Jaundice, weight loss, fatigue, malaise, appetite loss, nausea, chills, digestive discomfort
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired medication given to patient.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Diarrhoea, Dizziness, Extra dose administered, Gait disturbance
Clinical narrative: At about 3am on 5/23/22 (received vaccine at 5pm on 5/20/22) when I was sleeping and turned over I experienced vertigo, strong sense of motion and spinning, I was able to sleep but this happened several times throughout the night. Upon waking I could steady myself but it was feeling of disequilibrium, off balance and wobbly throughout the morning, although I could work, also had some nausea and very mild diarrhea. I was able to eat and hydrate and by mid-day I was not nauseous but still unsteady but not as bad as in the morning. By nighttime that day it was improved. On 5/24/22, still have dizziness and mild unsteadiness at times, no gi problems.  This was my second booster and I have never experienced this before and have no reason to link it to anything else, I had not been anywhere since receiving the booster nor eaten or drank anything out of the usual. I have no underlying health conditions.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Sleep disorder, Vertigo
Clinical narrative: At about 3am on 5/23/22 (received vaccine at 5pm on 5/20/22) when I was sleeping and turned over I experienced vertigo, strong sense of motion and spinning, I was able to sleep but this happened several times throughout the night. Upon waking I could steady myself but it was feeling of disequilibrium, off balance and wobbly throughout the morning, although I could work, also had some nausea and very mild diarrhea. I was able to eat and hydrate and by mid-day I was not nauseous but still unsteady but not as bad as in the morning. By nighttime that day it was improved. On 5/24/22, still have dizziness and mild unsteadiness at times, no gi problems.  This was my second booster and I have never experienced this before and have no reason to link it to anything else, I had not been anywhere since receiving the booster nor eaten or drank anything out of the usual. I have no underlying health conditions.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: Dose 1 given 2/10/2021 Moderna Lot # 024M20A  Patient tested positive for Covid on 5/22/2022, died on 5/23/2022 at hospital.
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Atrial fibrillation, COVID-19, Cardiac arrest, Death, Dyspnoea
Clinical narrative: Pt had become increasingly short of breath over the last 2 days.  He had a history of cardiac and pulmonary disease.  He had newly diagnosed A. fib.  He was found to be COVID positive with possible secondary bacterial pneumonia.  Prior to admission he went into PEA arrest and was pronounced dead.
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Pulseless electrical activity, SARS-CoV-2 test positive
Clinical narrative: Pt had become increasingly short of breath over the last 2 days.  He had a history of cardiac and pulmonary disease.  He had newly diagnosed A. fib.  He was found to be COVID positive with possible secondary bacterial pneumonia.  Prior to admission he went into PEA arrest and was pronounced dead.
Age: 63.0
Sex: F
Vaccine: FLU4, TDAP
Symptoms: Circumstance or information capable of leading to medication error, Extra dose administered, No adverse event
Clinical narrative: This nurse gave a flu shot to the patient using system information that was not the most recent. Record nurse received was blank (name misspelled). Patient stated she had a copy of her record. Patient also stated her school wanted certain shots completed for registration. Pt reported receiving a flu shot last fall before surgery but had no documentation. This shot was not listed on her report. This nurse advised patient that flu shots are the only vaccination that can be accepted for reporting as a self-attestation, so she did not have to get a flu shot today but the date can be added to her record if she was sure she received it and knew the date. The patient was not completely sure and decided to get another flu shot, which was given. When her current report was accessed, the previous flu shot was listed. Pt was informed and monitored for an additional 20 minutes without incident.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Aphonia, Pruritus, Skin warm, Throat tightness, Vaccination site induration
Clinical narrative: approx 30mm induration reported on left arm in area of vaccination, c/o itching and warm to touch. Pt c/o throat feeling tight and losing voice.  After sips of water, states sensation went away.  Pt educated on allergic reactions, need to call emergency if throat feels like it is closing, and to apply ice to area of arm.
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Pre-existing disease
Clinical narrative: death due to preexisting condition within 2 weeks of vaccination